Artificial intelligence is rapidly transforming the field of drug discovery, with companies like Lila Sciences and Recursion Pharmaceuticals leading the way. These companies are leveraging AI scaling laws and building platforms that can accelerate the identification of new treatments and reshape scientific exploration.
